DI BONAVENTURA, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 10.271
EU - Europa 7.774
AS - Asia 6.816
SA - Sud America 713
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 12
Totale 25.705
Nazione #
US - Stati Uniti d'America 10.091
SG - Singapore 2.738
CN - Cina 1.952
RU - Federazione Russa 1.450
IT - Italia 1.280
IE - Irlanda 998
UA - Ucraina 995
GB - Regno Unito 871
SE - Svezia 722
TR - Turchia 713
BR - Brasile 565
VN - Vietnam 559
FR - Francia 494
DE - Germania 453
IN - India 320
FI - Finlandia 213
HK - Hong Kong 127
CA - Canada 91
BD - Bangladesh 67
MX - Messico 67
JP - Giappone 61
IQ - Iraq 57
AR - Argentina 55
ES - Italia 53
PL - Polonia 48
NL - Olanda 42
AT - Austria 38
ZA - Sudafrica 36
KR - Corea 30
CZ - Repubblica Ceca 23
EC - Ecuador 23
VE - Venezuela 21
BE - Belgio 19
PK - Pakistan 19
SA - Arabia Saudita 19
CH - Svizzera 18
MA - Marocco 18
ID - Indonesia 17
LT - Lituania 15
MY - Malesia 15
CO - Colombia 14
IL - Israele 14
LB - Libano 13
UZ - Uzbekistan 12
EG - Egitto 11
EU - Europa 11
IR - Iran 11
KE - Kenya 11
CL - Cile 10
JO - Giordania 10
TH - Thailandia 10
PH - Filippine 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
TN - Tunisia 8
AU - Australia 7
PE - Perù 7
NP - Nepal 6
RS - Serbia 6
UY - Uruguay 6
CR - Costa Rica 5
GR - Grecia 5
OM - Oman 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DK - Danimarca 4
DZ - Algeria 4
PT - Portogallo 4
RO - Romania 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AL - Albania 3
AO - Angola 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
TW - Taiwan 3
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
NG - Nigeria 2
NI - Nicaragua 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
EE - Estonia 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
Totale 25.688
Città #
Singapore 1.971
Chandler 1.323
Jacksonville 1.199
San Jose 1.138
Dublin 993
Dearborn 642
Ashburn 639
Southend 574
Dallas 533
Beijing 496
Princeton 475
Izmir 376
Nanjing 344
Los Angeles 220
Chieti 200
Santa Clara 187
Wilmington 184
Cambridge 182
Ho Chi Minh City 177
Tongling 151
The Dalles 131
Nanchang 125
Altamura 120
Buffalo 116
Ann Arbor 113
Hong Kong 113
Moscow 113
Hanoi 112
New York 110
Boardman 90
Munich 87
Rome 73
Kunming 71
São Paulo 65
Orem 64
Pescara 63
Council Bluffs 62
Shenyang 60
Hebei 59
Redondo Beach 58
Dong Ket 49
Tokyo 46
Jiaxing 45
Washington 42
Woodbridge 41
Tianjin 40
Milan 39
Chennai 38
Chicago 37
Hefei 37
Warsaw 37
Norwalk 36
Brooklyn 33
Vienna 32
Montreal 31
Da Nang 29
Frankfurt am Main 29
Stockholm 29
Changsha 28
Amsterdam 27
Boston 27
Houston 27
Atlanta 26
Pune 24
Toronto 24
Hangzhou 23
Phoenix 23
Johannesburg 22
Poplar 22
Mumbai 21
Nuremberg 21
Seoul 21
Augusta 20
Baghdad 20
Civitanova Marche 20
Grevenbroich 20
Jinan 20
Mexico City 20
Seattle 20
Haiphong 19
San Mateo 19
Brussels 18
London 18
Guangzhou 17
Orange 17
San Francisco 17
Zhengzhou 17
Ankara 16
Denver 16
Düsseldorf 16
Rio de Janeiro 16
Ancona 15
Helsinki 15
Turku 15
Brno 14
Dhaka 14
Kocaeli 14
Manchester 14
Palermo 14
Lanzhou 13
Totale 15.289
Nome #
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 804
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 220
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: Microbiological, clinical and economic evaluation 199
Streptococcus dysgalactiae subsp. equisimilis: two cases of tonsillitis. 187
Effetto post-antibiotico di levofloxacina e grepafloxacina nei confronti di Stenotrophomonas maltophilia. 186
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 181
Unusual oropharyngeal asymptomatic manifestations caused by atypical pathogens detected by PCR into altered ecosystems of an infertile couple. 168
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 167
Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients. 166
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 157
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 156
Colonic adenoma-associated Escherichia coli express specific phenotypes 156
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 150
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 149
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 146
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 146
Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. 144
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 144
A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study). 142
Accuracy of flagella’s staining in the diagnosis of Helicobacter pylori infection: comparative study with the hystology, culture, and rapid urease test. 141
In vitro microbiology studies on a new peritoneal dialysis connector 140
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 140
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. 138
First report of an acute purulent maxillary sinusitis caused by Pseudomonas aeruginosa secondary to dental implant placement in an immunocompetent patient. 135
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 135
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. 134
Accuratezza di Etest per lo studio di attività in vitro di combinazioni tra fluorochinoloni e cefalosporine di terza generazione verso Pseudomonas aeruginosa. 133
Monitoraggio microbiologico di aria e superfici in ambiente di prime cure chirurgiche di ambulatorio INAIL. 133
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 133
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 133
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients 132
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 132
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 131
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 130
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 129
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 129
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 129
Accuratezza di E test nella determinazione in vitro della sensibilità di stafilococchi isolati da pazienti neutropenici verso levofloxacina. 127
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 127
Accuratezza di E test per il monitoraggio dell’antibiotico-sensibilità di Pseudomonas aeruginosa isolati da pazienti sottoposti a cateterismo vescicale. 126
Two cases of vaginitis caused by itraconazole-resistant saccharomyces cerevisiae and a review of recently published studies. 125
Sensibilità in vitro ai fluorichinoloni di Stenotrophomonas maltophilia isolati da pazienti neutropenici. 125
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 125
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 125
null 125
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. 124
Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report. 124
Comparison of the E test to agar dilution and broth microdilution methods for quantitative antimicrobial susceptibility testing of Helicobacter pylori. 124
Normal breathing releases SARS-CoV-2 into the air 123
Isolamento di Actinobacillus actinomycetemcomitans nella placca sottogengivale di pazienti portatori di apparecchiature ortodontiche 122
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 122
Development of a nanocomposite membrane based on reduced graphene (r-GO) and zeolite 13X for the removal of metal ions with bactericidal actions 122
Ottimale sopravvivenza di Actinobacillus actinomycetemcomitans sotto varie condizioni di trasporto. 121
A case ofpharyngitis caused by Streptococcus pneumoniae. 121
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 121
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 120
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 119
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 119
Antibiotico-resistenza di gram-negativi isolati in Terapia Intensiva nel triennio 1996-1998. 119
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 119
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 119
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 118
Evaluation of the E Test for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates from Patients with Long-Term Bladder Catheterization 118
Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. 118
Attività in vitro di levofloxacina verso isolati clinici da pazienti neutropenici. 118
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 118
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 117
In vitro activity of clarithromycin against intracellular Helicobacter pylori. 117
Frequency of detection of Actinobacillus actinomycetemcomitans in young patients during fixed orthodontic therapy. 116
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-Based methods 116
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 116
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 116
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 115
Attività in vitro di roxitromicina in confronto con eritromicina verso Actinobacillus actinomycetemcomitans. 115
Nuovi sistemi emocolturali automatici, ESP 128 (Difco) e Bact/Alert (Organon Teknika): analisi comparativa. 115
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 114
Methicillin-resistant Staphylococcus pseudintermedius infection in a bone marrow transplant recipient 114
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 113
P Role of the antibiotic sensitivity test before helicobacter pylori eradication treatments in naive patients 113
Hafnia alvei from the farm to the delivery room 113
Produzione di biofilm in ceppi di Listeria monocytogenes isolati da matrice ittica: correlation con motilità ed idrofobicità cellulare. 112
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 112
Contribution of the Leifson stain to the detection of Helicobacter pylori from antral biopsy specimens. 112
Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori (T. Alarcon, D. Domingo, M. Lopez-Brea). Author’s Reply. 112
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 112
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 112
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 112
In Vitro Viability of External Eye Microbial Flora in Hydroxy-Propyl-Methylcellulose 111
Identificazione di ceppi di Acinetobacter baumannii appartenenti a cloni epidemici mediante sequenziamento di geni coinvolti nella produzione di biofilm. 111
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 111
Caratterizzazione fenotipica e genotipica della formazione di biofilm da parte di Stenotrophomonas maltophilia isolati da pazienti con fibrosi cistica. 111
Effetti dell’antibiotico-resistenza di H. pylori sulle terapie eradicanti. 111
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 110
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 110
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 110
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 110
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 110
Spiral and coccoid forms of H. pylori in gastric mucosa biopsies: an electron microscopy study. 110
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 109
Ricerca di Helicobacter pylori tramite PCR su biopsie gastriche sottoposte al test rapido all’ureasi (CP-test). 109
Totale 13.536
Categoria #
all - tutte 97.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021372 0 0 0 0 0 0 0 0 0 212 53 107
2021/20221.270 40 47 34 218 107 22 43 111 122 40 143 343
2022/20233.433 288 423 215 416 341 652 203 261 441 42 99 52
2023/20241.468 122 75 90 46 116 381 368 71 16 48 10 125
2024/20253.743 248 614 464 115 88 146 136 159 472 184 441 676
2025/20268.130 590 344 874 885 848 429 1.518 619 1.417 606 0 0
Totale 26.691